エピソード

  • Chronic Lymphocytic Leukemia | Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
    2024/11/23

    Featuring perspectives from Dr Nicole Lamanna, including the following topics:

    • Introduction (0:00)
    • Case: A man in his late 60s with IGHV-mutated chronic lymphocytic leukemia (CLL) (trisomy 12) and progressive adenopathy — Bhavana (Tina) Bhatnagar, DO (1:22)
    • Case: A woman in her mid 70s with IGHV-unmutated, del(13q) CLL and fatigue — Erik Rupard, MD (19:57)
    • Case: A woman in her mid 80s with del(13q) CLL under watchful waiting develops progressive symptoms — Shams Bufalino, MD (30:00)
    • Case: A woman in her early 60s diagnosed with small lymphocytic leukemia (SLL) now with disease progression on ibrutinib — Warren S Brenner, MD (33:08)
    • Current role of pirtobrutinib; CAR T-cell therapy; Richter’s transformation — Dr Brenner (36:04)
    • Case: A man in his mid 40s with SLL who received second-line venetoclax/rituximab — Yanjun Ma, MD (50:01)

    CME information and select publications

    続きを読む 一部表示
    59 分
  • Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor (Companion Faculty Lecture)
    2024/11/21

    Featuring a slide presentation and related discussion from Dr Emanuela Palmerini, including the following topics:

    • Background, diagnosis and disease course of tenosynovial giant cell tumor (TGCT) (0:00)
    • Clinical data supporting systemic therapy for TGCT (10:19)
    • Clinical data on emerging therapies for TGCT (17:28)
    • Conclusion and future directions for TGCT (22:02)

    CME information and select publications

    続きを読む 一部表示
    25 分
  • Tenosynovial Giant Cell Tumor | Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor
    2024/11/21

    Featuring an interview with Dr Emanuela Palmerini, including the following topics:

    • Pathology, clinical presentation, diagnosis and workup of tenosynovial giant cell tumor (TGCT) (0:00)
    • Local therapies for and surgical management of TGCT (20:28)
    • Available systemic therapies for TGCT (30:31)
    • Investigational agents under development for TGCT (49:13)
    • Patient case presentations (55:54)

    CME information and select publications

    続きを読む 一部表示
    1 時間 4 分
  • Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
    2024/11/20

    Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O’Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics:

    • Introduction (0:00)
    • Updates in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma — Dr Kahl (1:10)
    • Updates in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Dr S Smith (33:32)

    CME information and select publications

    続きを読む 一部表示
    56 分
  • Prostate Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
    2024/11/20

    Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O’Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics:

    • Introduction (0:00)
    • Role of Hormonal Therapy in Prostate Cancer Management — Dr M Smith (10:54)
    • Other Available and Emerging Therapeutic Approaches — Dr Srinivas (37:03)

    CME information and select publications

    続きを読む 一部表示
    57 分
  • Hormone Receptor-Positive Metastatic Breast Cancer | Hope S Rugo, MD
    2024/11/19

    Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities — Hope S Rugo, MD

    CME information and select publications

    続きを読む 一部表示
    44 分
  • Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
    2024/11/19

    Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics:

    • Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00)
    • First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04)
    • Treatment Options for Recurrent mBC with PI3K/AKT/PTEN Mutations (24:11)
    • Beyond the Guidelines Survey (35:36)
    • Faculty Case Presentations (51:27)

    CME information and select publications

    続きを読む 一部表示
    57 分
  • Lung Cancer | Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
    2024/11/16

    Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O’Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics:

    • Introduction (0:00)
    • Nontargeted Therapy for Lung Cancer — Dr Goldberg (9:07)
    • Targeted Therapy for Non-Small Cell Lung Cancer — Dr Sabari (51:19)

    CME information and select publications

    続きを読む 一部表示
    1 時間 6 分